McLaughlin Melissa

Track

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
9 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
McLaughlin Melissa's trades of Alnylam Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-07 2026-04-06
PlS Planned sale
74,017 -27.8%
188.42
US$4,079,095 		74,017 -27.8% 188.42 US$4,079,095
2026-04-07 2026-04-06
PlS Planned sale
41,192 +23.2%
425.63
US$2,116,539 		41,192 +23.2% 425.63 US$2,116,539
2026-04-07 2026-04-06
PlS Planned sale
74,086 -0.5%
397.28
US$1,348,681 		74,086 -0.5% 397.28 US$1,348,681
2026-04-07 2026-04-06
PlS Planned sale
909 -7.8%
329.76
US$299,752 		909 -7.8% 329.76 US$299,752
2026-04-07 2026-04-06
PlS Planned sale
56 -0.5%
320.14
US$17,928 		56 -0.5% 320.14 US$17,928
2026-04-06 2026-04-06
PrS Proposed sale
2,286
320.10
US$731,749 		2,286 320.10 US$731,749
2026-04-07 2026-04-02
S Sale
8 -0.1%
325.49
US$2,604 		8 -0.1% 325.49 US$2,604
2026-04-07 2026-04-02
S Sale
81 -0.7%
323.64
US$26,215 		81 -0.7% 323.64 US$26,215
2026-04-07 2026-04-02
S Sale
245 -2.0%
322.86
US$79,101 		245 -2.0% 322.86 US$79,101
2026-04-07 2026-04-02
S Sale
224 -1.8%
321.64
US$72,047 		224 -1.8% 321.64 US$72,047
2026-04-07 2026-04-02
S Sale
147 -1.2%
320.62
US$47,131 		147 -1.2% 320.62 US$47,131
2026-04-07 2026-04-02
S Sale
86 -0.7%
319.69
US$27,493 		86 -0.7% 319.69 US$27,493
2026-04-07 2026-04-02
S Sale
209 -1.6%
318.47
US$66,560 		209 -1.6% 318.47 US$66,560
2026-04-07 2026-04-02
S Sale
359 -2.7%
317.44
US$113,961 		359 -2.7% 317.44 US$113,961
2026-04-07 2026-04-02
S Sale
265 -2.0%
316.61
US$83,902 		265 -2.0% 316.61 US$83,902